Quick Wins for COPD: Pharmacist Strategies for Effective Management

Although the number of Canadians diagnosed with COPD is high (2 million), it is estimated that an additional one million with COPD are undiagnosed and untreated. Unlike many other conditions, the prevalence of COPD is increasing and pharmacists are ideally positioned to support people with COPD with the current evidence-based treatment recommendations.

Course Author: Michael Boivin, Bsc, Phm, RPH, CDE 

This course is accredited by CCCEP for 1.5 CEU; CCCEP #1329-2024-3862-I-P

Learning Objectives:

1. Describe the key recommendations from the Canadian Thoracic Society (CTS) guidelines for COPD management.
2. Determine interventions the pharmacist can implement to improve outcomes in patients with COPD.
3. Explain the impact of acute exacerbations on mortality and morbidity.
4. Apply current guideline recommendations to reduce exacerbation risk in patients with COPD seen in pharmacy practice.

Supported by educational funding from AstraZeneca